While NTRK3 mutations have yet to be linked to response to ICIs, there is early evidence that NTRK3-mutated bladder cancers are more immunogenic, with increased TMB and enhanced immune infiltration compared to non-mutated tumors54. Here, NTRK3 is linked to urinary bladder cancer.